Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

April 27, 2016April 27, 2016

Potential Lymphoma Treatments Could Result from Scientific Insights Into Gene Regulating Enzymes

News

A British study recently revealed that class I histone deacetylases (HDACs) behave in an unexpected way when paired with a co-blocking molecule. The new insights into the control of these gene-regulating ... Read more

April 25, 2016April 25, 2016

Researchers Link Hepatitis C Virus to Head and Neck Cancers

News

A study from The University of Texas MD Anderson Cancer Center shows the hepatitis C infection, previously linked to liver cancer and non-Hodgkin’s lymphoma, is associated with cancers of the head ... Read more

April 21, 2016April 21, 2016

Difficult to Treat, Rare Lymphoma Seen to Respond to Combination of Cancer Drugs Under Development

News

New cancer drug candidates, used in combination, may benefit patients with ‘double-hit’ diffuse large B-cell lymphoma, a rare and treatment-resistant condition. The finding was in a study presented at the American Association ... Read more

April 19, 2016April 19, 2016

Clinical Trial of Chi-Med’s B-Cell Lymphoma Drug Is Launched

News

Hutchison China MediTech Limited, generally called Chi-Med, recently announced the initiation of its first-in-human Phase 1 clinical trial of HMPL-689, a drug the company aims to evaluate in B-cell malignancies. The ... Read more

April 15, 2016April 15, 2016

Antiviral Therapy Works as a Lymphoma Treatment in Patients with Hepatitis C, Study Reports

News

Antiviral therapy efficiently contributes to cancer treatment response in patients with hepatitis C virus infection and B-cell non-Hodgkin’s lymphoma, an analysis of previously published data revealed. The findings may change the ... Read more

April 13, 2016September 8, 2016

PET Scans Can Guide Chemotherapy Choices for Hodgkin’s Lymphoma, Study Reports

News

A study published in the Journal of Clinical Oncology shows for the first time a chemotherapy regimen determination —made after a mid-point assessment of treatment — that successfully treats more patients with ... Read more

April 11, 2016April 11, 2016

Genomic Data Helps to Match Young Cancer Patients with Unexpected Treatment Approaches

News

A project at the Genomics Institute of the University of California Santa Cruz combines high-tech networking with data sharing in an effort to allow clinicians to pick the right treatment for childhood ... Read more

March 31, 2016March 31, 2016

Study of Cutaneous T-cell Lymphoma Genomics Likely to Lead to Targeted Therapies Soon, Expert Says

News

Booming knowledge of how genomics contributes to cutaneous T-cell lymphoma is likely to lead the way to new, targeted treatments for this type of cancer in the near future, according to Pierluigi ... Read more

March 29, 2016March 29, 2016

Immunotherapy Showing Its Potential as Lymphoma Treatment, Mount Sinai Researcher Says

News

In a video posted in Healio, the director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai Hospital in New York, Joshua Brody, shares his enthusiastic view ... Read more

March 23, 2016March 23, 2016

Lymphoma Mutations Seen to Open Four ‘Locks’ on Key Protein to Promote Cancer

News

Researchers at Johns Hopkins have discovered that mutations in lymphoma cells allow these cells to break through four different locks on the protein CARD11, putting the protein in a constantly activated state ... Read more